Page 80 - 51 the significance--29.2_opt

121. Gomis R, Espadero RM, Jones R, Woerle HJ, Dugi KA. Efficacy and safety of initial
combination therapy with linagliptin and pioglitazone in patients with inadequately
controlled type 2 diabetes: a randomized, double-blind, placebo-controlled study.
Diabetes, obesity & metabolism 2011;13(7):653-61.
122. Koro CE, et al. Antidiabetic medication use and prevalence of chronic kidney
disease among patients with type 2 diabetes mellitus in the United States. Clin.
Therapeutics 2009;31(11):2608-17.
123. Vollmer K, Holst JJ, Baller B et al (2008) Predictors of incretin concentrations in subjects
with normal, impaired, and diabetic glucose tolerance. Diabetes 57:678–687.
124. Theodorakis MJ, Carlson O, Michopoulos S et al (2006) Human duodenal enteroen-
docrine cells: source of both incretin peptides, GLP-1 and GIP. Am J Physiol
(Endocrinol Metab) 290:E 550–559.
125. Muscelli E, Mari A, Casolaro A et al (2008) Separate impact of obesity and glucose
tolerance on the incretin effect in normal subjects and type 2 diabetic patients.
Diabetes 57:1340–1348.
126. Vilsbøll T, Krarup T, Sonne J et al (2003) Incretin secretion in relation to meal size and
body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
J Clin Endocrinol Metab 88:2706–2713.
127. Ryskjaer J, Deacon CF, Carr RD et al (2006) Plasma dipeptidyl peptidase-IV activity
in patients with type-2 diabetes mellitus correlates positively with HbA1c levels, but
is not acutely affected by food intake. Eur J Endocrinol 155:485–493.
128. Salinari S, Bertuzzi A, Asnaghi S, Guidone C, Manco M, Mingrone G (2009) First-phase
insulin secretion restoration and differential response to glucose load depending on
the route of administration in type 2 diabetic subjects after bariatric surgery. Diabetes
Care 32:375–380.
129. Knop FK, Vilsboll T, Hojberg PV, et al. The insulinotropic effect of GIP is impaired in
patients with chronic pancreatitis and secondary diabetes mellitus as compared
to patients with chronic pancreatitis and normal glucose tolerance. Regul Pept
2007;144(1-3):123-130.

80